ACR Expands Pilot Program Focused on AI and Radiology
|
By MedImaging International staff writers Posted on 06 Jul 2019 |

Image: The AI-LAB as a service provides a vendor-neutral framework to facilitate the development, modeling and validation of AI tools (Photo courtesy of ACR).
Radiology professionals from seven renowned health care institutions will use the ACR AI-LAB to demonstrate the process of creating investigational artificial intelligence (AI) models from image data without the use of a programming language. Using an AI model developed at one institution, each of the seven institutions will have the ability to evaluate and optimize the model for their own investigational use.
The American College of Radiology {(ACR), Reston, VA, USA} is making available the ACR AI-LAB as a service, which provides a vendor-neutral framework to facilitate the development, modeling and validation of AI tools. Based on the recently announced ACR AI-LAB reference architecture, this pilot represents a major milestone in the effort to allow institutions to develop high-quality algorithms that address local clinical needs, some of which may ultimately be made commercially available. In addition to the seven institutions, there are two major technology contributors; NVIDIA is providing software and edge infrastructure, and Nuance is providing last-mile integration to the participating radiologist.
The pilot – originally including Massachusetts General Hospital and The Ohio State University – now also includes Lahey Hospital and Medical Center, Emory University, The University of Washington, the University of California San Francisco and Brigham and Women’s Hospital. NVIDIA will provide its NVIDIA Clara AI software toolkits at no cost to the institutions to perform the annotation creation, transfer learning, and pipeline integration. In addition, Nuance will provide the last-mile technology required to integrate AI for the participating radiologist. Once the pilot is complete, the initiative is anticipated to progressively expand to all institutions interested in participating.
Sharing local AI models from image data between institutions for fine tuning — while patient information remains securely on site at the originating institution — has not previously been done successfully in radiology at this scale. This is due, in part, to the variability in how medical images are created, including the equipment, software, and protocols used. The pilot sites will use ACR AI-LAB to evaluate AI developed elsewhere, modifying the investigational algorithms to improve performance based on testing and evaluating them on local patient data. Creating the local AI models will not require ACR AI-LAB users to have programming skills. ACR AI-LAB allows users to adjust and change AI models without having to make line-by-line changes to the underlying code.
Once the pilot is complete, the consortium is anticipated to progressively expand to more institutions and vendors interested in participating. The investigational algorithms resulting from this project will undergo further evaluation and refinement by sites should they pursue commercialization, including obtaining appropriate regulatory clearance or approvals, as applicable.
“Today marks a major step in accelerating the development of AI for medical imaging. We know algorithms can underperform when deployed at sites where they weren’t trained. Now, radiologists in the pilot program will have access to AI algorithms developed outside their institutions in order evaluate a model’s performance using their own data and, as necessary, retrain the algorithm using their local data to enhance its performance,” said Bibb Allen Jr., MD, FACR, ACR Data Science Institute (ACR DSI) Chief Medical Officer.
“AI technology is entering the next phase where software writes software and less computer science expertise is required,” said Abdul Hamid Halabi, director of healthcare, at NVIDIA. “Radiologists have always been technology trailblazers. Working with the ACR AI-LAB to bring NVIDIA’s AI computing capability to the edge — where radiologists and their data reside — we are demonstrating that investigational AI tools can be made available to any imaging institution.”
Related Links:
American College of Radiology
The American College of Radiology {(ACR), Reston, VA, USA} is making available the ACR AI-LAB as a service, which provides a vendor-neutral framework to facilitate the development, modeling and validation of AI tools. Based on the recently announced ACR AI-LAB reference architecture, this pilot represents a major milestone in the effort to allow institutions to develop high-quality algorithms that address local clinical needs, some of which may ultimately be made commercially available. In addition to the seven institutions, there are two major technology contributors; NVIDIA is providing software and edge infrastructure, and Nuance is providing last-mile integration to the participating radiologist.
The pilot – originally including Massachusetts General Hospital and The Ohio State University – now also includes Lahey Hospital and Medical Center, Emory University, The University of Washington, the University of California San Francisco and Brigham and Women’s Hospital. NVIDIA will provide its NVIDIA Clara AI software toolkits at no cost to the institutions to perform the annotation creation, transfer learning, and pipeline integration. In addition, Nuance will provide the last-mile technology required to integrate AI for the participating radiologist. Once the pilot is complete, the initiative is anticipated to progressively expand to all institutions interested in participating.
Sharing local AI models from image data between institutions for fine tuning — while patient information remains securely on site at the originating institution — has not previously been done successfully in radiology at this scale. This is due, in part, to the variability in how medical images are created, including the equipment, software, and protocols used. The pilot sites will use ACR AI-LAB to evaluate AI developed elsewhere, modifying the investigational algorithms to improve performance based on testing and evaluating them on local patient data. Creating the local AI models will not require ACR AI-LAB users to have programming skills. ACR AI-LAB allows users to adjust and change AI models without having to make line-by-line changes to the underlying code.
Once the pilot is complete, the consortium is anticipated to progressively expand to more institutions and vendors interested in participating. The investigational algorithms resulting from this project will undergo further evaluation and refinement by sites should they pursue commercialization, including obtaining appropriate regulatory clearance or approvals, as applicable.
“Today marks a major step in accelerating the development of AI for medical imaging. We know algorithms can underperform when deployed at sites where they weren’t trained. Now, radiologists in the pilot program will have access to AI algorithms developed outside their institutions in order evaluate a model’s performance using their own data and, as necessary, retrain the algorithm using their local data to enhance its performance,” said Bibb Allen Jr., MD, FACR, ACR Data Science Institute (ACR DSI) Chief Medical Officer.
“AI technology is entering the next phase where software writes software and less computer science expertise is required,” said Abdul Hamid Halabi, director of healthcare, at NVIDIA. “Radiologists have always been technology trailblazers. Working with the ACR AI-LAB to bring NVIDIA’s AI computing capability to the edge — where radiologists and their data reside — we are demonstrating that investigational AI tools can be made available to any imaging institution.”
Related Links:
American College of Radiology
Latest Industry News News
- Nuclear Medicine Set for Continued Growth Driven by Demand for Precision Diagnostics
- GE HealthCare and NVIDIA Collaboration to Reimagine Diagnostic Imaging
- Patient-Specific 3D-Printed Phantoms Transform CT Imaging
- Siemens and Sectra Collaborate on Enhancing Radiology Workflows
- Bracco Diagnostics and ColoWatch Partner to Expand Availability CRC Screening Tests Using Virtual Colonoscopy
- Mindray Partners with TeleRay to Streamline Ultrasound Delivery
- Philips and Medtronic Partner on Stroke Care
- Siemens and Medtronic Enter into Global Partnership for Advancing Spine Care Imaging Technologies
- RSNA 2024 Technical Exhibits to Showcase Latest Advances in Radiology
- Bracco Collaborates with Arrayus on Microbubble-Assisted Focused Ultrasound Therapy for Pancreatic Cancer
- Innovative Collaboration to Enhance Ischemic Stroke Detection and Elevate Standards in Diagnostic Imaging
- RSNA 2024 Registration Opens
- Microsoft collaborates with Leading Academic Medical Systems to Advance AI in Medical Imaging
- GE HealthCare Acquires Intelligent Ultrasound Group’s Clinical Artificial Intelligence Business
- Bayer and Rad AI Collaborate on Expanding Use of Cutting Edge AI Radiology Operational Solutions
- Polish Med-Tech Company BrainScan to Expand Extensively into Foreign Markets
Channels
Radiography
view channel
AI Detection Tool Improves Identification of Lobular Breast Cancer
Breast cancer screening seeks early detection, yet some subtypes remain difficult to visualize on mammography, risking delayed diagnosis. On average, 1 in 20 women worldwide will develop breast cancer,... Read more
New Contrast Agent Enables Low-Dose X-Ray Joint Imaging
X-ray imaging offers limited visualization of soft tissues like cartilage, complicating evaluation of joint pain and degenerative disease. Clinicians often rely on joint-space narrowing as a proxy for... Read moreMRI
view channel
MRI Tool Enables Long-Term Tracking of Transplanted Cardiac Cells
Cell therapies for myocardial injury face a persistent hurdle: clinicians cannot easily monitor whether transplanted cells survive and where they persist in the heart. This limits optimization of dosing,... Read more
MRI-Based AI Tool Supports Differentiation of Parkinsonian Syndromes
Clinicians often struggle to differentiate Parkinsonian syndromes at initial presentation, when symptom overlap can obscure disease trajectory and delay targeted care. Imaging markers derived from diffusion... Read more
MRI-Derived Biomarker Improves Risk Stratification in Glioblastoma
Glioblastoma is marked by rapid growth and diffuse infiltration that complicate prognosis and treatment planning. Clinicians need objective tools that capture both how these tumors expand and how they... Read more
Combined Imaging Approach Identifies Cause of Heart Attack without Coronary Blockage
Patients who present with myocardial infarction but show no obstructive coronary disease often leave without a definitive diagnosis. That uncertainty complicates in-hospital decision-making and post-discharge... Read moreUltrasound
view channel
Whole Cross-Section Ultrasound System Enables Operator-Independent Imaging
Conventional ultrasound is central to bedside imaging but is limited by a narrow field of view and operator variability. Comprehensive cross-sectional assessment typically requires computed tomography... Read more
New Ultrasound AI Tool Supports Rapid Prenatal Assessment
Accurate gestational age estimation guides prenatal screening, detection of complications, and timely intervention. Access to ultrasound and trained sonographers is uneven, with nearly half of U.... Read moreNuclear Medicine
view channelMR-Guided Cardiac Mapping System Enables Radiation-Free Procedures
Cardiac electrophysiology procedures are typically guided by X-ray fluoroscopy, which limits soft-tissue visualization and exposes patients and clinical staff to ionizing radiation. Real-time mapping that... Read more
PET Tracer Enables Noninvasive Measurement of Beta Cell Mass
Type 1 diabetes is an autoimmune disease in which the immune system destroys insulin-producing pancreatic beta cells. Loss of these cells destabilizes glucose control and drives complications.... Read more
New Imaging Tool Sheds Light on Tumor Fat Metabolism
Rapidly growing tumors reprogram metabolism to meet high energy demands. While many cancers preferentially consume glucose, lipid utilization by malignant cells is difficult to measure in living subjects.... Read more
Radiopharmaceutical Molecule Marker to Improve Choice of Bladder Cancer Therapies
Targeted cancer therapies only work when tumor cells express the specific molecular structures they are designed to attack. In urothelial carcinoma, a common form of bladder cancer, the cell surface protein... Read moreGeneral/Advanced Imaging
view channel
Routine Cardiac CT Enhanced to Predict Heart Failure Risk
Heart failure, a progressive inability of the heart to pump blood effectively, often develops silently before symptoms appear. Clinicians need reliable ways to detect myocardial injury early and stratify... Read more
New Breast Imaging Viewer Unifies Modalities and Enhances Clinical Workflow
Breast evaluation often requires correlating findings from mammography, digital breast tomosynthesis, MRI, ultrasound, and newer volumetric techniques. Switching between separate viewers to track changes... Read moreImaging IT
view channel
Breast Imaging Software Enhances Visualization and Tissue Characterization in Challenging Cases
Breast imaging can be particularly challenging in cases involving small breasts or implants, where image reconstruction and tissue characterization may be limited. Clinicians also need reproducible analysis... Read more
New Google Cloud Medical Imaging Suite Makes Imaging Healthcare Data More Accessible
Medical imaging is a critical tool used to diagnose patients, and there are billions of medical images scanned globally each year. Imaging data accounts for about 90% of all healthcare data1 and, until... Read more







